Detection of germline mutations in MLH1, MSH2, PMS2, MSH6 and APC is used to identify individuals with a predisposition for developing hereditary nonpolyposis colon cancer (HNPCC) and familial adenomatous polyposis (FAP), respectively. Here, MLH1 is linked to hereditary nonpolyposis colon cancer.